BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14990693)

  • 1. Human rhinovirus type 2-antibody complexes enter and infect cells via Fc-gamma receptor IIB1.
    Baravalle G; Brabec M; Snyers L; Blaas D; Fuchs R
    J Virol; 2004 Mar; 78(6):2729-37. PubMed ID: 14990693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational changes, plasma membrane penetration, and infection by human rhinovirus type 2: role of receptors and low pH.
    Brabec M; Baravalle G; Blaas D; Fuchs R
    J Virol; 2003 May; 77(9):5370-7. PubMed ID: 12692239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of a neutralizing antibody bound monovalently to human rhinovirus 2.
    Hewat EA; Marlovits TC; Blaas D
    J Virol; 1998 May; 72(5):4396-402. PubMed ID: 9557730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wortmannin delays transfer of human rhinovirus serotype 2 to late endocytic compartments.
    Brabec M; Blaas D; Fuchs R
    Biochem Biophys Res Commun; 2006 Sep; 348(2):741-9. PubMed ID: 16890915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A neutralizing epitope on human rhinovirus type 2 includes amino acid residues between 153 and 164 of virus capsid protein VP2.
    Skern T; Neubauer C; Frasel L; Gründler P; Sommergruber W; Zorn M; Kuechler E; Blaas D
    J Gen Virol; 1987 Feb; 68 ( Pt 2)():315-23. PubMed ID: 2434607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated endosomal pH in HeLa cells overexpressing mutant dynamin can affect infection by pH-sensitive viruses.
    Huber M; Brabec M; Bayer N; Blaas D; Fuchs R
    Traffic; 2001 Oct; 2(10):727-36. PubMed ID: 11576449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of clathrin-dependent endocytosis has multiple effects on human rhinovirus serotype 2 cell entry.
    Bayer N; Schober D; Hüttinger M; Blaas D; Fuchs R
    J Biol Chem; 2001 Feb; 276(6):3952-62. PubMed ID: 11073943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of bafilomycin A1 and nocodazole on endocytic transport in HeLa cells: implications for viral uncoating and infection.
    Bayer N; Schober D; Prchla E; Murphy RF; Blaas D; Fuchs R
    J Virol; 1998 Dec; 72(12):9645-55. PubMed ID: 9811698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low pH-triggered beta-propeller switch of the low-density lipoprotein receptor assists rhinovirus infection.
    Konecsni T; Berka U; Pickl-Herk A; Bilek G; Khan AG; Gajdzig L; Fuchs R; Blaas D
    J Virol; 2009 Nov; 83(21):10922-30. PubMed ID: 19706701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of human rhinovirus serotype 2 (HRV2).
    Verdaguer N; Blaas D; Fita I
    J Mol Biol; 2000 Jul; 300(5):1179-94. PubMed ID: 10903863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of a neutralizing antibody bound bivalently to human rhinovirus 2.
    Hewat EA; Blaas D
    EMBO J; 1996 Apr; 15(7):1515-23. PubMed ID: 8612574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human rhinovirus type 2 is internalized by clathrin-mediated endocytosis.
    Snyers L; Zwickl H; Blaas D
    J Virol; 2003 May; 77(9):5360-9. PubMed ID: 12692238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docking of a human rhinovirus neutralizing antibody onto the viral capsid.
    Tormo J; Centeno NB; Fontana E; Bubendorfer T; Fita I; Blaas D
    Proteins; 1995 Dec; 23(4):491-501. PubMed ID: 8749845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncoating of human rhinovirus serotype 2 from late endosomes.
    Prchla E; Kuechler E; Blaas D; Fuchs R
    J Virol; 1994 Jun; 68(6):3713-23. PubMed ID: 8189509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryoelectron microscopy analysis of the structural changes associated with human rhinovirus type 14 uncoating.
    Hewat EA; Blaas D
    J Virol; 2004 Mar; 78(6):2935-42. PubMed ID: 14990711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opening of size-selective pores in endosomes during human rhinovirus serotype 2 in vivo uncoating monitored by single-organelle flow analysis.
    Brabec M; Schober D; Wagner E; Bayer N; Murphy RF; Blaas D; Fuchs R
    J Virol; 2005 Jan; 79(2):1008-16. PubMed ID: 15613329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site of human rhinovirus RNA uncoating revealed by fluorescent in situ hybridization.
    Brabec-Zaruba M; Pfanzagl B; Blaas D; Fuchs R
    J Virol; 2009 Apr; 83(8):3770-7. PubMed ID: 19158243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Entry of human rhinovirus 89 via ICAM-1 into HeLa epithelial cells is inhibited by actin skeleton disruption and by bafilomycin.
    Pfanzagl B; Andergassen D; Edlmayr J; Niespodziana K; Valenta R; Blaas D
    Arch Virol; 2014 Jan; 159(1):125-40. PubMed ID: 23913188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhinovirus-mediated endosomal release of transfection complexes.
    Zauner W; Blaas D; Kuechler E; Wagner E
    J Virol; 1995 Feb; 69(2):1085-92. PubMed ID: 7815487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affinity capillary electrophoresis for the assessment of complex formation between viruses and monoclonal antibodies.
    Okun VM; Ronacher B; Blaas D; Kenndler E
    Anal Chem; 2000 Oct; 72(19):4634-9. PubMed ID: 11028622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.